In their informative article, Halpern et al1 point out that intensivists' decisions to pursue nonconsented testing are often associated with erroneous understandings and perceptions of state laws. The authors propose uniform standards for nonconsented testing. We agree that such a policy would be optimal. Although appealing in its simplicity, this solution may not be immediately—if at all—feasible or accepted, since each state writes its own laws. The lack of national conformity regarding nonconsented testing can be expected to continue. Because of the complexity and variability of these laws, as well as recent changes in many states' laws, intensivists and other clinicians will need make decisions that are—or are perceived to be—at odds with state laws. The misunderstanding of state laws mentioned by Halpern et al1 is central to this problem. The National HIV/AIDS Clinicians' Consultation Center (NCCC) of the University of California, San Francisco, San Francisco General Hospital, has produced the “Compendium of State HIV/AIDS Testing Laws”2 (the Compendium) that can assist clinicians in meeting these challenging dilemmas. The Compendium is updated periodically as state laws change. Because of the tediousness of sifting through laws and the challenges in interpreting complex legal language, the Compendium has a “Quick Reference Guide” for each state that summarizes pertinent laws for clinicians. In addition, the NCCC's “Warmline” (telephone: 800-933-3413) can answer additional questions on human immunodeficiency virus testing and management. These services can help intensivists make clinically appropriate decisions while understanding how these decisions conform to state laws.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Users' Guides to the Medical Literature
For example, a trial of intravenous immunoglobulin in advanced human immunodeficiency infection...
The Rational Clinical Examination
Evidence Summary and Review 3
All results at
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.